Artificial Intelligence Reshaping the Cell and Gene Therapy Manufacturing Landscape, New BCC Research Report Finds

AI, robotics, and machine learning are converging to overcome longstanding CGT manufacturing bottlenecks as biopharma investment surges.Boston, March 18, 2026 (GLOBE NEWSWIRE) — A new BCC Research Pulse Report reveals that artificial intelligence is rapidly transforming the global cell and gene therapy (CGT) tools and reagents market, as venture capital and private equity firms pour billions into AI-driven biotechnology companies seeking to overcome longstanding manufacturing bottlenecks. The r